Guangying Du
Key Laboratory Of Molecular Pharmacology And Drug Evaluation
Yantai, 264005, China
Yantai, 264005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting ME1 rescues redox-metabolic coordination in ALS: A core effector of NRF2-directed therapy.
Targeting ME1 rescues redox-metabolic coordination in ALS: A core effector of NRF2-directed therapy.
Journal: Neuropharmacology
Published: December 08, 2025
Pharmacodynamics, safety pharmacology and local tolerance of rotigotine behenate extended-release microspheres.
Journal: Toxicology and applied pharmacology
Published: March 24, 2025
Synthesis and evaluation of novel 5-HT2A receptor inverse agonist with excellent in vivo antipsychotic efficacy and superior tissue distribution for treatment of Parkinson's disease psychosis.
Journal: European journal of medicinal chemistry
Published: March 11, 2025
Non-clinical pharmacology and toxicology studies of LPM6690061, a novel 5-hydroxytryptamine (5-HT)2A receptor inverse agonist.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: January 31, 2023
9-Cyclopropylmethoxy-dihydrotetrabenazine and its stereoisomers as vesicular monoamine transporter-2 inhibitors.
Journal: Future medicinal chemistry
Published: May 31, 2022
Improving the treatment of Parkinson's disease: Structure-based development of novel 5-HT2A receptor antagonists/inverse agonists.
Journal: European journal of medicinal chemistry
Published: December 04, 2021
(+)-9-Trifluoroethoxy-α-Dihydrotetrabenazine as a Highly Potent Vesicular Monoamine Transporter 2 Inhibitor for Tardive Dyskinesia.
Journal: Frontiers in pharmacology
Published: September 03, 2021
Synthesis and analysis of dihydrotetrabenazine derivatives as novel vesicular monoamine transporter 2 inhibitors.
Journal: European journal of medicinal chemistry
Published: May 08, 2021
Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2.
Journal: Communications biology
Published: November 04, 2020
Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects.
Journal: International journal of immunopathology and pharmacology
Published: September 23, 2020
Last Updated: 09/26/2026